Overall Status

Completed (46)

Terminated (5)

Recruiting (1)

Phase

phase 3 (46)

n/a (2)

phase 2 (1)

phase 2/phase 3 (1)

phase 4 (1)

Sponsor

Novo Nordisk A/S (44)

Asahi Kasei Pharma Corporation (1)

Diasome Pharmaceuticals (1)

Healthy.io Ltd. (1)

Jaeb Center for Health Research (1)

Lovoria Williams (1)

Takeda (1)

University of Virginia (1)

Yale University (1)

Collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2)

National Institute of Neurological Disorders and Stroke (NINDS) (2)

Medical University of South Carolina (1)

National Eye Institute (NEI) (1)

Neurological Emergencies Treatment Trials Network (NETT) (1)

Takeda Pharmaceuticals North America, Inc. (1)

Study Documents

Intervention Type

drug (47)

behavioral (2)

device (2)

Funder Type

Industry (48)

Other (4)

Study Type

Interventional (51)

Observational (1)

Diabetes

Showing NaN - NaN of 52

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Diabetes, Diabetic Retinopathy Trial in United States (Diabetes Education)

Completed

Diabetes
Diabetic Retinopathy

Diabetes Education

Loma Linda, California
+33 more

Aug 25, 2016

Hypertension, Diabetes Trial in United States (Placebo, Azilsartan medoxomil)

Terminated

Has Results

Hypertension
Diabetes

Placebo
Azilsartan medoxomil

Birmingham, Alabama
+67 more

Apr 20, 2015